C1orf167 is a gene that may interact with the drugs aripiprazole and methotrexate through non-pharmacokinetic pathways, potentially affecting drug effectiveness or side effects via unknown molecular or cellular mechanisms. The specific pharmacogenetic role of C1orf167 is not well-understood, and its interactions with these drugs remain speculative and not clearly defined within known drug metabolism or response categories.